CAR-T Generation for Identity, Purity and Potency Assay Testing - YouTube
A functional assay for serum detection of antibodies against SARS‐CoV‐2 nucleoprotein | The EMBO Journal
Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
Biomolecules | Free Full-Text | Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene: Molecular Therapy - Methods & Clinical Development
Potency assays for ATMPs: overcoming challenges on the path to commercialization - Insights From Our Labs to Yours
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo | bioRxiv
IJMS | Free Full-Text | Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
Accelerating Biologic and Biosimilar Drug Development: Ready-to-Use, Cell-Based Assays for Potency and Lot-Release Testing - BioProcess InternationalBioProcess International
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants - ScienceDirect
A personal perspective of the development and validation of a phase-specific antibody–drug conjugate cytotoxicity potency assay | Bioanalysis
Dual potency assays. (A) Dual potency assay with anti-TNF-α antibody,... | Download Scientific Diagram
Surrogate potency assays: Comparison of binding profiles complements dose response curves for unambiguous assessment of relative potencies - ScienceDirect
VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines | npj Vaccines
A personal perspective of the development and validation of a phase-specific antibody–drug conjugate cytotoxicity potency assay | Bioanalysis
Mechanism of action of TDB1 and the reporter-gene potency assay. (a).... | Download Scientific Diagram
Molecular and functional analysis of monoclonal antibodies in support of biologics development | SpringerLink
COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity
Accelerating Biologic and Biosimilar Drug Development: Ready-to-Use, Cell-Based Assays for Potency and Lot-Release Testing - BioProcess InternationalBioProcess International
Drug Lot Release Potency Assay / Testing - Marin Biologic Laboratories
